v3.26.1
STOCK-BASED COMPENSATION (Tables)
3 Months Ended
Mar. 31, 2026
Share-Based Payment Arrangement [Abstract]  
SUMMARY OF STOCK-BASED COMPENSATION EXPENSE RECOGNIZED FOR STOCK OPTION AWARDS

The Company has recorded stock-based compensation expense related to the issuance of restricted stock awards in the following line items in the accompanying condensed consolidated statements of operations:

 

   2026   2025 
  

Three Months Ended March 31,

 
   2026   2025 
         
Research and development  $1,074   $21,250 
General and administrative   13,266    305,366 
Total stock-based compensation expense  $14,340   $326,616 
SUMMARY OF OPTION ACTIVITY

The following table summarizes stock option activity under the 2014 Plan and 2024 Plan:

 

  

Number of

options

  

Weighted-average

exercise price

  

Weighted-average

 remaining contractual

term (in years)

  

Aggregate

intrinsic value

 
Outstanding at December 31, 2025   9,055   $211.56    3.67     
Granted                
Exercised                
Forfeited                
Outstanding at March 31, 2026   9,055   $211.56    3.42     
                     
Vested and exercisable at March 31, 2026   9,055   $211.56    3.42     
SUMMARY OF RESTRICTED STOCK AWARD

The following table summarizes restricted stock award activity under the 2014 Plan and 2024 Plan:

 

   Number of           As of March 31, 2026 
  

restricted

stock awards

(RSA)

  

Weighted-

average

grant price

  

FMV on

grant date

  

Vested

number

of RSA

  

Unvested

number

of RSA

 
Balance at December 31, 2025   51,810   $51.87   $2,709,982    47,951    3,859 
Granted                    
Forfeited                    
Balance at March 31, 2026   51,810   $51.87   $2,709,982    47,951    3,859